Methylene Blue for Treatment of Hospitalized COVID-19 Patients: A Randomized, Controlled, Open-Label Clinical Trial, Phase 2-Reference-Cited by-同舟云学术

Methylene Blue for Treatment of Hospitalized COVID-19 Patients: A Randomized, Controlled, Open-Label Clinical Trial, Phase 2

Published:2021-05-13 Issue:3 Volume:73 Page:
ISSN:0034-8376
Container-title:Revista de investigaci�n Cl�nica
language:en
Short-container-title:RIC

Author:

Hamidi-Alamdari Daryoush,Hafizi-Lotfabadi Saied,Bagheri-Moghaddam Ahmad,Safari Hossin,Mozdourian Mahnaz,Javidarabshahi Zahra,Peivandi-Yazdi Arash,Ali-Zeraati Abass,Sedaghat Alireza,Poursadegh Farid,Barazandeh-Ahmadabadi Fatemeh,Agheli-Rad Marzieh,Tavousi Seyed M.,Vojouhi Shohreh,Amini Shahram,Amini Mahnaz,Majid-Hosseini Seyed,Tavanaee-Sani Ashraf,Ghiabi Amin,Nabavi-Mahalli Shima,Morovatdar Negar,Rajabi Omid,Koliakos George

Publisher

Publicidad Permanyer, SLU

Subject

General Medicine

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methylene blue for COVID-19 ARDS: insights from a randomized Clinical Trial;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-29

2. Challenges of consolidating evidence collected during a pandemic and lessons for the future;Current Medical Research and Opinion;2024-07-23

3. Application of methylene blue for the prevention and treatment of COVID-19: A narrative review;IRAN J BASIC MED SCI;2024

4. Antimicrobial Activity of Methylene Blue Associated with Photodynamic Therapy: In Vitro Study in Multi-Species Oral Biofilm;Pathogens;2024-04-21

5. Effects of evidence-based clinical practice guidelines for COVID-19 in health care quality improvements. A third systematic review.;F1000Research;2023-11-24